These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 18070875)
1. Malin decreases glycogen accumulation by promoting the degradation of protein targeting to glycogen (PTG). Worby CA; Gentry MS; Dixon JE J Biol Chem; 2008 Feb; 283(7):4069-76. PubMed ID: 18070875 [TBL] [Abstract][Full Text] [Related]
2. AMP-activated protein kinase phosphorylates R5/PTG, the glycogen targeting subunit of the R5/PTG-protein phosphatase 1 holoenzyme, and accelerates its down-regulation by the laforin-malin complex. Vernia S; Solaz-Fuster MC; Gimeno-Alcañiz JV; Rubio T; García-Haro L; Foretz M; de Córdoba SR; Sanz P J Biol Chem; 2009 Mar; 284(13):8247-55. PubMed ID: 19171932 [TBL] [Abstract][Full Text] [Related]
3. Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway. Solaz-Fuster MC; Gimeno-Alcañiz JV; Ros S; Fernandez-Sanchez ME; Garcia-Fojeda B; Criado Garcia O; Vilchez D; Dominguez J; Garcia-Rocha M; Sanchez-Piris M; Aguado C; Knecht E; Serratosa J; Guinovart JJ; Sanz P; Rodriguez de Córdoba S Hum Mol Genet; 2008 Mar; 17(5):667-78. PubMed ID: 18029386 [TBL] [Abstract][Full Text] [Related]
4. Increased endoplasmic reticulum stress and decreased proteasomal function in lafora disease models lacking the phosphatase laforin. Vernia S; Rubio T; Heredia M; Rodríguez de Córdoba S; Sanz P PLoS One; 2009 Jun; 4(6):e5907. PubMed ID: 19529779 [TBL] [Abstract][Full Text] [Related]
5. Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation. Fernández-Sánchez ME; Criado-García O; Heath KE; García-Fojeda B; Medraño-Fernández I; Gomez-Garre P; Sanz P; Serratosa JM; Rodríguez de Córdoba S Hum Mol Genet; 2003 Dec; 12(23):3161-71. PubMed ID: 14532330 [TBL] [Abstract][Full Text] [Related]
7. Impaired malin expression and interaction with partner proteins in Lafora disease. Skurat AV; Segvich DM; Contreras CJ; Hu YC; Hurley TD; DePaoli-Roach AA; Roach PJ J Biol Chem; 2024 May; 300(5):107271. PubMed ID: 38588813 [TBL] [Abstract][Full Text] [Related]
8. Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin. DePaoli-Roach AA; Tagliabracci VS; Segvich DM; Meyer CM; Irimia JM; Roach PJ J Biol Chem; 2010 Aug; 285(33):25372-81. PubMed ID: 20538597 [TBL] [Abstract][Full Text] [Related]
9. Increased laforin and laforin binding to glycogen underlie Lafora body formation in malin-deficient Lafora disease. Tiberia E; Turnbull J; Wang T; Ruggieri A; Zhao XC; Pencea N; Israelian J; Wang Y; Ackerley CA; Wang P; Liu Y; Minassian BA J Biol Chem; 2012 Jul; 287(30):25650-9. PubMed ID: 22669944 [TBL] [Abstract][Full Text] [Related]
10. Laforin-malin complex degrades polyglucosan bodies in concert with glycogen debranching enzyme and brain isoform glycogen phosphorylase. Liu Y; Zeng L; Ma K; Baba O; Zheng P; Liu Y; Wang Y Mol Neurobiol; 2014 Apr; 49(2):645-57. PubMed ID: 24068615 [TBL] [Abstract][Full Text] [Related]
11. Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy. Mitra S; Chen B; Wang P; Chown EE; Dear M; Guisso DR; Mariam U; Wu J; Gumusgoz E; Minassian BA Dis Model Mech; 2023 Jan; 16(1):. PubMed ID: 36511140 [TBL] [Abstract][Full Text] [Related]
12. Deciphering the role of malin in the lafora progressive myoclonus epilepsy. Romá-Mateo C; Sanz P; Gentry MS IUBMB Life; 2012 Oct; 64(10):801-8. PubMed ID: 22815132 [TBL] [Abstract][Full Text] [Related]
13. Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin. Gentry MS; Worby CA; Dixon JE Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8501-6. PubMed ID: 15930137 [TBL] [Abstract][Full Text] [Related]
14. Regulation of the autophagic PI3KC3 complex by laforin/malin E3-ubiquitin ligase, two proteins involved in Lafora disease. Sanchez-Martin P; Lahuerta M; Viana R; Knecht E; Sanz P Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118613. PubMed ID: 31758957 [TBL] [Abstract][Full Text] [Related]
15. Lafora disease proteins laforin and malin negatively regulate the HIPK2-p53 cell death pathway. Upadhyay M; Gupta S; Bhadauriya P; Ganesh S Biochem Biophys Res Commun; 2015 Aug; 464(1):106-11. PubMed ID: 26102034 [TBL] [Abstract][Full Text] [Related]
17. Glycogenic activity of R6, a protein phosphatase 1 regulatory subunit, is modulated by the laforin-malin complex. Rubio-Villena C; Garcia-Gimeno MA; Sanz P Int J Biochem Cell Biol; 2013 Jul; 45(7):1479-88. PubMed ID: 23624058 [TBL] [Abstract][Full Text] [Related]
18. Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease. Nitschke F; Sullivan MA; Wang P; Zhao X; Chown EE; Perri AM; Israelian L; Juana-López L; Bovolenta P; Rodríguez de Córdoba S; Steup M; Minassian BA EMBO Mol Med; 2017 Jul; 9(7):906-917. PubMed ID: 28536304 [TBL] [Abstract][Full Text] [Related]
19. Lafora disease: Current biology and therapeutic approaches. Mitra S; Gumusgoz E; Minassian BA Rev Neurol (Paris); 2022 Apr; 178(4):315-325. PubMed ID: 34301405 [TBL] [Abstract][Full Text] [Related]
20. Laforin is required for the functional activation of malin in endoplasmic reticulum stress resistance in neuronal cells. Zeng L; Wang Y; Baba O; Zheng P; Liu Y; Liu Y FEBS J; 2012 Jul; 279(14):2467-78. PubMed ID: 22578008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]